337 related articles for article (PubMed ID: 27493101)
21. Synergistic efficacy of γ-radiation together with gallium trichloride and/or doxorubicin against Ehrlich carcinoma in female mice.
Kandil E; Aziz NA
Tumour Biol; 2016 Feb; 37(2):1825-34. PubMed ID: 26318299
[TBL] [Abstract][Full Text] [Related]
22. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
El-Sisi AE; Sokkar SS; Ibrahim HA; Hamed MF; Abu-Risha SE
Fundam Clin Pharmacol; 2020 Aug; 34(4):458-475. PubMed ID: 32080901
[TBL] [Abstract][Full Text] [Related]
23. Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.
El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
Tumour Biol; 2017 May; 39(5):1010428317692235. PubMed ID: 28459206
[TBL] [Abstract][Full Text] [Related]
24. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.
Li S; Yuan S; Zhao Q; Wang B; Wang X; Li K
Biomed Pharmacother; 2018 Apr; 100():441-447. PubMed ID: 29475141
[TBL] [Abstract][Full Text] [Related]
25. Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
Tun JO; Salvador-Reyes LA; Velarde MC; Saito N; Suwanborirux K; Concepcion GP
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527453
[TBL] [Abstract][Full Text] [Related]
26. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
[TBL] [Abstract][Full Text] [Related]
27. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
Zhong T; Xu F; Xu J; Liu L; Chen Y
Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
[TBL] [Abstract][Full Text] [Related]
28. Luteolin attenuates doxorubicin-induced cytotoxicity to MCF-7 human breast cancer cells.
Sato Y; Sasaki N; Saito M; Endo N; Kugawa F; Ueno A
Biol Pharm Bull; 2015; 38(5):703-9. PubMed ID: 25947916
[TBL] [Abstract][Full Text] [Related]
29. A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells.
Wang L; Zhang X; Chan JY; Shan L; Cui G; Cui Q; Wang Y; Li J; Chen H; Zhang Q; Yu P; Han Y; Wang Y; Lee SM
J Cell Biochem; 2016 Jan; 117(1):94-105. PubMed ID: 26058377
[TBL] [Abstract][Full Text] [Related]
30. Synergic Effects of Doxorubicin and Melatonin on Apoptosis and Mitochondrial Oxidative Stress in MCF-7 Breast Cancer Cells: Involvement of TRPV1 Channels.
Koşar PA; Nazıroğlu M; Övey İS; Çiğ B
J Membr Biol; 2016 Apr; 249(1-2):129-40. PubMed ID: 26525975
[TBL] [Abstract][Full Text] [Related]
31. Expression of Bax, Bad and Bcl-2 proteins under x-radiation effect towards human breast carcinoma MCF-7 cells and their doxorubicin-resistant derivatives.
Chorna IV; Datsyuk LO; Stoika RS
Exp Oncol; 2005 Sep; 27(3):196-201. PubMed ID: 16244580
[TBL] [Abstract][Full Text] [Related]
32. Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin.
Bontempo A; Ugalde-Villanueva B; Delgado-González E; Rodríguez ÁL; Aceves C
Oncol Rep; 2017 Nov; 38(5):2867-2876. PubMed ID: 28901484
[TBL] [Abstract][Full Text] [Related]
33. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
[TBL] [Abstract][Full Text] [Related]
34. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
36. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells.
Datta A; Bhasin N; Kim H; Ranjan M; Rider B; Abd Elmageed ZY; Mondal D; Agrawal KC; Abdel-Mageed AB
Cancer Lett; 2015 Jun; 362(1):25-35. PubMed ID: 25796439
[TBL] [Abstract][Full Text] [Related]
37. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.
Zoli W; Ulivi P; Tesei A; Fabbri F; Rosetti M; Maltoni R; Giunchi DC; Ricotti L; Brigliadori G; Vannini I; Amadori D
Breast Cancer Res; 2005; 7(5):R681-9. PubMed ID: 16168113
[TBL] [Abstract][Full Text] [Related]
38. [1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice.
WalyEldeen AA; El-Shorbagy HM; Hassaneen HM; Abdelhamid IA; Sabet S; Ibrahim SA
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1225-1238. PubMed ID: 35881165
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of probimane on anticancer cytotoxicity of doxorubicin in vitro.
Zhang Y; Ye QX; Liu J; Zhang ZY; Zhang TM
Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):56-9. PubMed ID: 8010087
[TBL] [Abstract][Full Text] [Related]
40. Acid-Sensitive Peptide-Conjugated Doxorubicin Mediates the Lysosomal Pathway of Apoptosis and Reverses Drug Resistance in Breast Cancer.
Sheng Y; Xu J; You Y; Xu F; Chen Y
Mol Pharm; 2015 Jul; 12(7):2217-28. PubMed ID: 26035464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]